This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamamoto, T. Articles by Mizuno, K. Search for Related Content PubMed PubMed Citation Articles by Yamamoto, T. Articles by Mizuno, K.

Use of hydroxyapatite to fill cavities after excision of benign bone tumours

CLINICAL RESULTS

¹ Department of Orthopaedic Surgery, Kobe University School of Medicine, Kobe 650-0017, Japan.

Correspondence should be sent to Dr T. Yamamoto.

We treated 75 patients with benign bone tumours by curettage and filling the defect with calcium hydroxyapatite (HA). There were 28 women and 47 men with a mean age of 27.7 years (3 to 80). The mean follow-up was for 41.3 months. Postoperative radiological assessment revealed that the implanted HA was well incorporated into the surrounding host bone in all patients. Two patients suffered fractures in the postoperative period. Two patients complained of pain associated with HA in the soft tissues, but this diminished within six months. No patient had local pain at the final follow-up. Recurrence of the tumour was seen in three cases. Histopathological study of the implanted area showed removal of the HA by histiocytes and multinucleated giant cells, and the formation of much appositional bone. We conclude that HA is an excellent bone-graft substitute in surgery for benign bone tumours.

This article has been cited by other articles:

				H. Tsuchiya, A. F. Morsy, H. Matsubara, K. Watanabe, M. E. Abdel-Wanis, and K. Tomita Treatment of benign bone tumours using external fixation J Bone Joint Surg Br, August 1, 2007; 89-B(8): 1077 - 1083. [Abstract] [Full Text] [PDF]